Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom

Archives of Disease in Childhood

Volumn 87, Issue 3, 2002, Pages 178-180

  Sharland, M ^a   Gibb, D M ^b   Tudor Williams, G ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; ZIDOVUDINE;

CHILD; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; PEDIATRICS; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; UNITED KINGDOM; VERTICAL TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; DISEASE TRANSMISSION, VERTICAL; HIV INFECTIONS; HUMANS;

EID: 0036724318     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.87.3.178     Document Type: Short Survey

References (28)

1. Paediatric HIV infection
2. Improvement in antenatal screening for HIV in the United Kingdom
3. Cost effectiveness analysis of antenatal HIV screening in the United Kingdom
4. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection
5. Reducing mother to baby transmission of HIV
6. Antenatal detection of HIV: National surveillance and unlinked anonymous survey
7. Perinatal transmission of HIV-1 from pregnant women with RNA viral load less than 1000 copies/ml
8. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
9. Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial
10. Risk of human immunodeficiency virus type 1 transmission through breast feeding
11. British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy
12. Vertical transmission of HIV in the British Isles: Estimates based on surveillance data
13. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
14. Lack of definitive severe mitochondrial signs or symptoms among deceased HIV uninfected and HIV indeterminate children <5 years of age, Pediatric Spectrum of Disease Project (PSD), USA
15. Factors affecting uptake of antenatal HIV testing in London: Results of a multicentre study
16. Uptake of antenatal screening for HIV infection can be high outside London too
17. Late diagnosis of paediatric HIV infection in south west London
18. A sexual health and HIV strategy for England
19. Five year follow up of vertically HIV infected children in a randomised double blind controlled trail of immediate versus deferred zidovudine: The PENTA 1 trial
20. Effects of antiretroviral therapy (ART) on morbidity and mortality of the UK and Irish HIV infected children
21. PENTA guidelines for antiretroviral therapy use in HIV infected children
22. Paediatric antiretroviral therapy audit in south London
23. Morbidity among HIV-1 infected children and uninfected African children